Adrenal vein sampling vs. CT scan to determine treatment in primary aldosteronism: An outcome-based randomised diagnostic trial
Tanja Dekkers(Radboud University Nijmegen), Jaap Deinum(Radboud University Nijmegen), Wilko Spiering(Utrecht University), Bert‐Jan H. van den Born(Amsterdam University Medical Centers), Marieke Velema(Slingeland Ziekenhuis), A.F. Lighthart-Naber, Jacek Kądziela(Institute of Cardiology), Gert Jan van der Wilt(Radboud University Nijmegen), Mark Arntz(Radboud University Nijmegen), A. R. M. M. Hermus(Radboud University Nijmegen), Andrzej Januszewicz(Hypertension Institute), J.F. Langenhuijsen(Radboud University Nijmegen), Leo J. Schultze Kool(University of Alberta Hospital), Aleksander Prejbisz(Institute of Cardiology), Sylwia Kołodziejczyk‐Kruk(Institute of Cardiology), F.C.G.J. Sweep, Anton H. van den Meiracker(Erasmus MC), J.M.M. Groenewoud(Radboud University Nijmegen), Jacques W.M. Lenders(Radboud University Nijmegen), M. N. Kerstens(Radboud University Nijmegen), Péter Makai(Radboud University Nijmegen)
Cited by 1
Related Papers
2018 ESC/ESH Guidelines for the management of arterial hypertension
|European Heart Journal|2018|10.5k
Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort
|The Lancet Diabetes & Endocrinology|2017|951
An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis
|The Lancet Oncology|2009|536